Information about GenomiX
My details
*
*
*

GenomiX (SRL)

BE

0757.949.684

Company information

Status
Active

Enterprise number

BE0757.949.684

VAT liability
No
Established
10-11-2020
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from GenomiX

2025 2024 2023 2022
Income statement
Profit/Loss € 9,134 0% € 9,135 -2% € 9,316 -28% € 13,027
Gross margin € -1,109 16% € -1,314 -62% € -812 -
Balance sheet
Balance sheet total € 343,875 3% € 332,295 2% € 325,289 4% € 313,105
Equity € 255,524 4% € 246,391 4% € 237,255 4% € 227,939
Debts € 88,350 3% € 85,904 -2% € 88,034 3% € 85,166

Publications from GenomiX

Date Publication
22-12-2023 Resignations, Appointments (FR)
13-11-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of GenomiX?
The enterprise number of GenomiX is BE 0757.949.684.
Wat is the PEPPOL ID of GenomiX?
There is no information available about the PEPPOL ID of GenomiX or the company is not yet registered on the PEPPOL network.
When was GenomiX founded?
GenomiX was founded on 10-11-2020.
What is the address of GenomiX?
The current registered office of GenomiX is located at Allée de la Cense-Rouge 9, 4031 Liège.
When was the last time GenomiX filed their annual financial statements?
The most recent financial statements of GenomiX were filed on 02-09-2026.
How many employees does GenomiX have?
There are currently no employees working at GenomiX or no workforce information is available.
What is the annual turnover of GenomiX?
At the time of its most recent financial statements, GenomiX did not publish any turnover figures. GenomiX reported a gross margin of -€1,109.33.

Sources